XOMA Royalty Corp. (XOMA)

27.04 +1.72 (+6.79%) USD  |  NASDAQ  |  Feb 24, 16:00
26.84 -0.20 (-0.74%) Pre-Market: 20:00
More

XOMA Royalty Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for XOMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Mirum Pharmaceuticals, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Rezolute, Inc. Upgrade
DiaMedica Therapeutics, Inc. Upgrade
Gossamer Bio, Inc. Upgrade